Accelerated Stability Assessment With Luminata®

Accelerated stability studies play a critical role in predicting shelf life early in drug development, but the path from raw analytical data to reliable forecasts is often fragmented and manual. A more integrated approach connects chromatographic results, degradation pathways, and humidity‑modified Arrhenius modeling in a single workflow. By reducing data transcription and automating key calculations, stability predictions become faster, more consistent, and easier to interpret. Visualization tools further support decision‑making by comparing degradant formation rates, forecasting long‑term behavior, and aligning results with downstream safety considerations. This approach is especially valuable when working with limited structural information, enabling meaningful insights even in early development phases.
Explore how a unified platform can streamline accelerated stability assessment, minimize experimental burden, and support smarter development decisions with greater confidence.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.